CCG-203971

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 3092

CAS [1443437-74-8]

MF C23H21ClN2O3
MW 408.88

CCG-203971

Description

CCG-203971 is an inhibitor of the Rho/MKL1/SRF-mediated gene transcription pathway (IC50 value of 4.2 μM).

KEYWORDS: CCG-203971 | supplier | Rho/MRTF/SRF inhibitor | CCG203971 | CCG 203971 | CAS [1443437-74-8] | Metastatic melanoma

Cell Signaling & Oncology Transcription Factors TGF-β EC 2.7.11.1 Rho

Rho/MRTF/SRF transcriptional pathway inhibitor

N-(4-Chlorophenyl)-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

[1443437-74-8]

Order

Size	Unit Price	Stock
10 mg	€60.00	In Stock
50 mg	€180.00	In Stock

Need more? Bulk Inquiry

Axon ID	Name	Description
1167	GSK 269962A	ROCK1 and ROCK2 inhibitor	€65.00
1535	Thiazovivin	ROCK inhibitor and iPSC stimulator; Stem cell related	€90.00
1683	Y 27632 dihydrochloride	ROCK1 and ROCK2 inhibitor	€65.00
2166	AT 13148 dihydrochloride	ATP-competitive inhibitor of multi-AGC kinases	€70.00
2187	AS 1892802	Potent, selective, ATP-competitive ROCK inhibitor	€95.00
2229	RKI 1447	Potent inhibitor of the Rho-associated ROCK kinases	€105.00
5009	Stem Cell 4i inhibitor Set	Set of Thiazovivin, SB 431542, PD0325901, and CHIR99021 (inhibitors of ROCK, TGF-β, MEK, and GSK-3 resp.)	€170.00
5010	Naive Stem Cell NHSM inhibitor Set	Set of inhibitors for isolation, generation, derivatization and stabilization of naive hPSCs	€230.00
5011	Naive Stem Cell 5i inhibitor Set	Set of five inhibitors for the induction and maintenance of human naive stem cell pluripotency	€200.00
2753	CCG 232601	Rho/MRTF/SRF transcriptional pathway inhibitor	€160.00
2780	KD025	Selective ATP-competitive inhibitor of ROCK2	€95.00
3069	CCG-222740	Potent and selective Rho/MRTF/SRF transcriptional pathway inhibitor	€145.00